Company Presentations /
by -
A year ago
09 Jul 2019 - Alterity Therapeutics Limited (ASX:ATH) CEO & Chairman, Geoffrey Kempler, presents on the company's lead drug candidate, the potential applications for the drug and t…
Interviews /
by Katrina Bullock -
A year ago
09 Jul 2019 - Alterity Therapeutics Limited (ASX:ATH) CEO & Chairman, Geoffrey Kempler, discusses the company’s development pipeline and lead drug candidate PTB434 for use treating…
